Literature DB >> 20391981

Association of Schistosoma haematobium and human papillomavirus in cervical cancer: a case report.

Lalita S Savardekar1, Donta Balaiah, Bapurao N Mali.   

Abstract

BACKGROUND: The association between Schistosoma haematobium and cervical cancer has been reported for a long time. However, recently human papillomavirus, a cofactor in the genesis of cervical cancer, has been confirmed. A case of squamous intraepithelial lesion after S haematobium infection is presented, and the relation between schistosomiasis, human papillomavirus and squamous intraepithelial lesion, with long-term follow-up by Papanicolaou smear, is discussed. CASE: A 33-year-old, normal, healthy woman with a history of Copper intrauterine device (IUD) use for 3.9 years presented for her annual contraceptive follow-up. Her Pap smear revealed inflammation with a S haematobium egg. She was followed up with Pap smears for 4 years. Retrospective contraceptive history revealed use ofa copper IUD on 5 occasions with a total duration of 13 years and 1 month. Similarly, annual follow-up of Pap smears for the past 13 years showed mild inflammation with bacterial vaginitis and monilial infection. Subsequent smears showed an Actinomyces-like organism and then human papillomavirus infection with atypical squamous cells of undetermined significance followed by human papillomavirus-associated low/high grade squamous intraepithelial lesion.
CONCLUSION: Caution is required while screening routine Pap smears. Apart from nuclear abnormalities, one can observe unusual findings. Long-term followup by Pap smear following detection of S haematobium revealed that in the absence of human papillomavirus, S haematobium alone is not the causative agent for the abnormal proliferation of squamous epithelium of the cervix. Genital Schistosomia acts as a cofactor by traumatizing the genital epithelium or immune suppression to favor human papillomavirus infection.

Entities:  

Mesh:

Year:  2010        PMID: 20391981     DOI: 10.1159/000325011

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  7 in total

1.  Assessing the WHO 50% prevalence threshold in school-aged children as indication for treatment of urogenital schistosomiasis in adults in central Nigeria.

Authors:  Darin S Evans; Jonathan D King; Abel Eigege; John Umaru; William Adamani; Kal Alphonsus; Yohanna Sambo; Emmanual S Miri; Danjuma Goshit; Gladys Ogah; Frank O Richards
Journal:  Am J Trop Med Hyg       Date:  2013-02-04       Impact factor: 2.345

Review 2.  Schistosome infections: an Indian perspective.

Authors:  Arunava Kali
Journal:  J Clin Diagn Res       Date:  2015-02-01

3.  Cystic Presentation of Hepatic Schistosomiasis.

Authors:  Vikrant Sood; Sachin Ramesh Chaudhari; Deeplaxmi Borle; Binit Sureka; Chhagan Bihari; Senthil Kumar
Journal:  Indian J Pediatr       Date:  2017-09-19       Impact factor: 1.967

4.  Evaluating the variation in the projected benefit of community-wide mass treatment for schistosomiasis: Implications for future economic evaluations.

Authors:  Hugo C Turner; James E Truscott; Alison A Bettis; Sam H Farrell; Arminder K Deol; Jane M Whitton; Fiona M Fleming; Roy M Anderson
Journal:  Parasit Vectors       Date:  2017-04-28       Impact factor: 3.876

Review 5.  The role of helminths in the development of non-communicable diseases.

Authors:  Yifan Wu; Megan Duffey; Saira Elizabeth Alex; Charlie Suarez-Reyes; Eva H Clark; Jill E Weatherhead
Journal:  Front Immunol       Date:  2022-08-31       Impact factor: 8.786

6.  Cytomorphology of unusual infectious entities in the Pap test.

Authors:  Walid E Khalbuss; Pam Michelow; Cynthia Benedict; Sara E Monaco; Liron Pantanowitz
Journal:  Cytojournal       Date:  2012-06-29       Impact factor: 2.091

7.  Schistosoma haematobium hotspots in south Nyanza, western Kenya: prevalence, distribution and co-endemicity with Schistosoma mansoni and soil-transmitted helminths.

Authors:  Huldah C Sang; Geoffrey Muchiri; Maurice Ombok; Maurice R Odiere; Pauline N M Mwinzi
Journal:  Parasit Vectors       Date:  2014-03-25       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.